Early detection is critical in improving outcomes for colorectal cancer and other bowel diseases. Non-invasive diagnostic tools such as the Faecal Immunochemical Test (FIT) and faecal calprotectin are transforming how clinicians identify and differentiate gastrointestinal conditions. By enabling accurate, evidence-based assessment, these tests support earlier intervention, more precise diagnoses, and improved patient care pathways.